News & Events

  • June 15, 2016

    Champions Oncology Inc. announced the closing of their underwritten public offering of Common Stock in the amount of $5,000,000.  EG&S acted as counsel to Champions Oncology.

  • June 15, 2016

    Cytori Therapeutics, Inc. announced the closing of their rights offering in the amount of approximately $17.1 million.  EG&S acted as counsel to the Dealer Manager.

  • June 14, 2016

    Kew Media Group Inc., a newly organized special purpose acquisition corporation, has announced the closing of its IPO in the amount of $70,000,000.  EG&S acted as U.S. legal counsel to Kew Media.

  • June 02, 2016

    The United States District Court for the Northern District of California recently granted the motion to dismiss a putative securities class action filed against our client Cellular Biomedicine Group, Inc. in the wake of a blog post by an anonymous short seller.  The court held that plaintiffs had not pled a corrective disclosure and therefore failed to plead loss causation.  Adrienne Ward and Michael Sullivan, members of the Firm, served as lead counsel.  A copy of the opinion is available here.

  • May 31, 2016

    Adrienne Ward and Bill Peterson, both members of the Firm, took part in a live webinar on Tuesday May 31, 2016 at 3pm EDT.  The webinar reviewed anti-money laundering (AML) issues that broker-dealer and investment adviser firms are currently facing, including FinCEN’s new Enhanced Due Diligence Rule, and provided an exam and enforcement update.

    Click here to view the recorded webinar.

  • May 26, 2016

    OncoSec Medical Incorporated announced the closing of their Registered Direct offering in the amount of $9,950,000.  EG&S acted as counsel to the Placement Agent.

  • May 26, 2016

    Legend Oil & Gas Ltd. announced the closing of their PIPE offering in the amount of $460,082.40.  EG&S acted as counsel to the Investor.

  • May 24, 2016

    IDI, Inc. announced the closing of their Registered Direct offering in the amount of $5,000,000.  EG&S acted as counsel to the Placement Agent.

  • May 23, 2016

    Cel-Sci Corporation announced the closing of their Registered Direct offering in the amount of $5,000,000.  EG&S acted as counsel to the Placement Agent.

  • May 20, 2016

    OpGen, Inc. announced the first closing of a private placement financing with registration rights, which will raise total gross proceeds of $10.4 million for the company.  EG&S acted as counsel to the sole lead placement agent, Cowen and Company, and Leerink Partners LLC as financial advisor.

  • May 19, 2016

    Client Alert: DOL Publishes Final Rule Revising FLSA Overtime Exemptions

    On May 18, 2016, the U.S. Department of Labor (“DOL”) published the final rule updating the overtime regulations (the “Final OT Rule”). 


    Click here to read the full alert.

  • May 18, 2016

    Inventergy Global, Inc. announced the closing of its registered direct offering of common stock and warrants for gross proceeds of approximately $1.3 million. EG&S acted as counsel to Inventergy.

  • May 18, 2016

    Inventergy Global Inc. announced the closing of their Registered Direct offering in the amount of $1,299,210. EG&S acted as counsel to the Company.

  • May 16, 2016

    Northwest Biotherapeutics Inc. announced the closing of their Warrant Reprice offering in the amount of $4,235,293.  EG&S acted as counsel to the Placement Agent.

  • May 13, 2016

    iDisclose, announced today that several of the leading new Title III Crowdfunding funding portals at various stages in the SEC and FINRA approval process will be using iDisclose either on an exclusive basis or as a tool they can offer to assist issuers on their portals.

    Click here to read more

  • May 13, 2016

    Synthesis Energy Systems Inc. announced the closing of their At the Market facility in the amount of $20,000,000.  EG&S acted as counsel to the Placement Agent.

  • May 13, 2016

    Inventergy Global Inc. announced the closing of their PIPE offering in the amount of $369,000.  EG&S acted as counsel to the Company.

  • May 12, 2016

    Mankind Corporation announced the closing of their Registered Direct offering in the amount of $50,000,000.  EG&S acted as counsel to the Placement Agent.

  • May 11, 2016

    James Landau, a member of the Firm, will be speaking on June 8, 2016 as part of a New York State Bar Association Panel on the collection and enforcement of money judgments.  Details can be found at the following link:

    http://www.nysba.org/store/events/registration.aspx?event=0EG67

  • May 11, 2016

    Sophiris Bio Inc. announced the closing of their Registered Direct offering in the amount of $5,000,000.  EG&S acted as counsel to the Placement Agent.

  • May 10, 2016

    GenVec Inc. announced the closing of their Registered Direct offering in the amount of $5,000,000.  EG&S acted as counsel to the Placement Agent.

  • May 09, 2016

    Tearlab Corp. announced the closing of their Registered Direct offering in the amount of $17,250,000.  EG&S acted as counsel to the Placement Agent.

  • May 06, 2016

    Golden Minerals Company announced the closing of their Registered Direct offering in the amount of $4,000,000.  EG&S acted as counsel to the Placement Agent.

  • May 04, 2016

    Biocept Inc. announced the closing of their Registered Direct offering in the amount of $4,986,573.  EG&S acted as counsel to the Placement Agent.

  • April 27, 2016

    James Landau, a member of the Firm, will be participating in a panel discussion at the NYC Bar entitled Pitch Perfect and Beyond:  Finding Your Inner Rainmaker.  The event will be held at the City Bar, 42 West 44th Street on May 4, 2016 starting at 6:30 pm.

    For further details and to register, click on the link:

    http://services.nycbar.org/EventDetail?EventKey=CAM05016&WebsiteKey=f71e12f3-524e-4f8c-a5f7-0d16ce7b3314